10-Q · August 6, 2025
Adient reported quarterly net sales of $3,741 million and GAAP diluted EPS of $0.43 for the three months ended June 30, 2025, with gross profit of $237 million and operating income of $118 million. Liquidity remains…
Earnings analysis · 10-Q
Filed May 6, 2026 · Our reading of the company's report
The latest report
Adient's Q2 2026 results showed a strong recovery with net sales increasing to $3.865 billion, up 7% year-over-year, and a turnaround in net income to $27 million from a loss of $335 million a year earlier. Operating…
Adient's Q2 2026 results showed a strong recovery with net sales increasing to $3.865 billion, up 7% year-over-year, and a turnaround in net income to $27 million from a loss of $335 million a year earlier. Operating margins improved despite some headwinds in production volumes, particularly in the EMEA region. The company is dealing with rising costs but has been able to recover some losses through strategic pricing adjustments.
How much of each revenue dollar the business keeps.
One point per quarterly or annual filing. Both margins are shares of that report's revenue.
Where each $100 of revenue went in this report.
Cost of sales, operating expenses, and what remained. Figures are rounded to whole dollars.
The business segments reported by the company.
Shares of the segments disclosed in this filing, largest first.
Our analysis across the last few reports.
Our model's reading of each filing, not the share price or the market's reaction. Annual and quarterly reports each occupy one position.
Net sales increased by $254 million, or 7%, year-over-year to $3.865 billion compared to $3.611 billion in Q2 2025.
Reported diluted EPS of $0.52 for Q2 2026, rebounding from a loss of $3.99 in the same quarter last year.
Operating cash flow was reported at $90 million, compared to a loss of $45 million a year ago.
Restructuring costs fell 99% to $5 million, down from $351 million in Q2 2025.
The Americas segment saw an 11% increase in net sales, reaching $1.884 billion.
SG&A expenses decreased by 4% to $138 million from $144 million in the prior year.
Overall production volumes decreased 0.9% globally, with North America and China seeing significant declines.
Adient's revenues are affected by foreign currency exchange rates, exposing it to potential financial volatility.
Ongoing geopolitical uncertainties, particularly from the Middle East and Ukraine, could elevate costs and disrupt supply chains.
No numerical guidance provided; management comments indicate a watchful approach due to external economic factors.
Adient reported quarterly net sales of $3,741 million and GAAP diluted EPS of $0.43 for the three months ended June 30, 2025, with gross profit of $237 million and operating income of $118 million. Liquidity remains…
Adient reported revenue of $3,611 million for the quarter ended March 31, 2025 (up $111 million QoQ from ~$3,500M and down $139 million YoY from $3,750M). Gross profit improved to $261 million (7.2% margin) but the…
Adient reported net sales of $3,495 million for the quarter ended December 31, 2024, down $165 million versus $3,660 million a year earlier. Gross profit fell to $216 million and operating income (EBIT) to $93 million,…
Adient reported Q3 net sales of $3,716 million and gross profit of $207 million, with operating income of $94 million but a loss attributable to Adient of $(11) million (diluted EPS $(0.12)). Revenue and gross profit…
This is our reading of a public filing, not the filing itself. Analysis can contain errors; check the source document for full context.